Industry

MedX Health has partnered with Central Health, the second largest health authority in Newfoundland and Labrador, to introduce DermSecure® Screening Platform Services to 176 communities across the province. MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, and Central Health are pleased to announce the launch of … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 375,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof), priced at a … [Read more…]

WHIPPANY, N.J.–(BUSINESS WIRE)–Stem & Root Daily Immunity was named “Product of the Year” in the immune support category at the prestigious NutraIngredients-USA Awards announced earlier this month. Stem & Root believes that the power of nature is best unlocked when proven by science. That’s why Stem & Root’s latest launch of a Daily Immunity supplement … [Read more…]

PALO ALTO, Calif.–(BUSINESS WIRE)–Stanford Health Care is among the top 10 hospitals in the nation, according to the U.S. News & World Report’s 2022-2023 Best Hospitals rankings. The hospital was named in the top three in California and the best in the San Jose metropolitan area. For the eighth consecutive year, Stanford Hospital was included … [Read more…]

ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2022. Fiscal 2023 First Quarter Highlights Total revenue was $153.3 million compared to $146.1 million for the same period a year ago, or 5% growth. Recurring revenue … [Read more…]

Teva has reached agreement in principle on the primary financial terms of a nationwide opioids settlement and has revised its provision to reflect its terms Key financial highlights and outlook Revenues of $3.8 billion GAAP diluted loss per share of $0.21 Non-GAAP diluted EPS of $0.68 Cash flow generated from operating activities of $123 million … [Read more…]

– The new Credit Facility provides an immediate and meaningful liquidity infusion, supporting working capital needs – Upon the satisfaction of certain post-closing conditions or business milestones, the Credit Facility allows for full access to the notional amount of $104.5 million – The convertible debt exchange results in both debt discount recapture and a path … [Read more…]

Second Quarter 2022 Highlights Reported EPS of $1.81, up 35% and record adjusted EPS of $2.02, up 15% vs. Q2 2021 Orders of $839 million, up 12% overall and 7% organically vs. Q2 2021 Record sales of $796 million, up 16% overall and 12% organically vs. Q2 2021 Reported operating margin of 23.4%, up 30 … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that Dr. Srinivas Akkaraju, Founder and Managing General Partner at Samsara BioCapital, has been appointed to Scholar Rock’s Board of Directors as an independent director. … [Read more…]

BROOKLYN, N.Y.–(BUSINESS WIRE)–Adit Ventures, a global venture capital firm with over $400 million in AUM, has agreed to seed Aanika Re, a Bermuda-based insurance vehicle wholly owned by Aanika Biosciences, inc. Aanika Re’s mandate is to leverage the microbial tagging technology developed by Aanika Biosciences, as well as a broader swath of biological innovations, to … [Read more…]